Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (51-60 of 503) with videos related to

Pageof 51
Sort By:
The Journal of Clinical Investigation|May 17, 2013
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemiaYe Chen, Rodrigo Jacamo, Marina Konopleva, et al.
Cancer|July 16, 2011
Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737Kensuke Kojima, Seshagiri Duvvuri, Vivian Ruvolo, et al.
Annals of Nuclear Medicine|November 29, 2008
Radiosynoviorthesis (RSO): influencing factors and therapy monitoringLidiya Zuderman, Knut Liepe, Klaus Zöphel, et al.
Blood|March 18, 2006
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemiaKensuke Kojima, Marina Konopleva, Teresa McQueen, et al.
Nano Biomedicine and Engineering|June 22, 2012
Laser nanothermolysis of human leukemia cells using functionalized plasmonic nanoparticlesAnton V Liopo, André Conjusteau, Marina Konopleva, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|March 1, 2021
TAM kinases as regulators of cell deathSean M Post, Michael Andreeff, Courtney DiNardo, et al.
STAR Protocols|October 18, 2024
Protocol for monitoring clonal hematopoiesis in transgenic mouse models using multispectral imagingPriyanka Khanna, Lauren B Ostermann, Shayaun Khazaei, et al.
Gynecologic Oncology|March 30, 2004
Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expressionBohuslav Melichar, Marina Konopleva, Wei Hu, et al.
International Journal of Hematology|August 7, 2007
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehiclesBrett Hall, Jennifer Dembinski, A Kate Sasser, et al.
Molecular & Cellular Oncology|June 17, 2016
GD2 and GD3 synthase: novel drug targets for cancer therapyNathalie Sphyris, Tapasree Roy Sarkar, Venkata L Battula, et al.
Pageof 51

Showing results (51-60 of 503) with videos related to

Sort By:
Pageof 51
The Journal of Clinical Investigation|May 17, 2013
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemiaYe Chen, Rodrigo Jacamo, Marina Konopleva, et al.
Cancer|July 16, 2011
Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737Kensuke Kojima, Seshagiri Duvvuri, Vivian Ruvolo, et al.
Annals of Nuclear Medicine|November 29, 2008
Radiosynoviorthesis (RSO): influencing factors and therapy monitoringLidiya Zuderman, Knut Liepe, Klaus Zöphel, et al.
Blood|March 18, 2006
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemiaKensuke Kojima, Marina Konopleva, Teresa McQueen, et al.
Nano Biomedicine and Engineering|June 22, 2012
Laser nanothermolysis of human leukemia cells using functionalized plasmonic nanoparticlesAnton V Liopo, André Conjusteau, Marina Konopleva, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|March 1, 2021
TAM kinases as regulators of cell deathSean M Post, Michael Andreeff, Courtney DiNardo, et al.
STAR Protocols|October 18, 2024
Protocol for monitoring clonal hematopoiesis in transgenic mouse models using multispectral imagingPriyanka Khanna, Lauren B Ostermann, Shayaun Khazaei, et al.
Gynecologic Oncology|March 30, 2004
Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expressionBohuslav Melichar, Marina Konopleva, Wei Hu, et al.
International Journal of Hematology|August 7, 2007
Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehiclesBrett Hall, Jennifer Dembinski, A Kate Sasser, et al.
Molecular & Cellular Oncology|June 17, 2016
GD2 and GD3 synthase: novel drug targets for cancer therapyNathalie Sphyris, Tapasree Roy Sarkar, Venkata L Battula, et al.
Pageof 51